The US has picked the DNA centers that will sequence 1 million genomes
A US precision medicine initiative is giving out $28.6 million to three gene sequencing centers to begin decoding the genomes of 1 million American volunteers.
So, what’s it for? The AllofUs study is “one of the country’s most ambitious biomedical research efforts ever undertaken,” according to the National Institutes of Health, which is running the project. It will track the health, diet, and environment of a million people of all races who have handed over their genetic data to the project. So far, more than 110,000 have signed up.
Who: Decoding the DNA of the American volunteers was a coveted job. The winners, announced today, are the Baylor College of Medicine in Texas, the Broad Institute in Cambridge, Massachusetts, and the University of Washington in Seattle.
Only one company, Color Genomics of Burlingame, California, was selected. It will join the Cambridge team and will help provide DNA interpretation and reports—something it does as part of its day-to-day gene testing business.
The sequencing centers picked weren’t exactly outside-the box choices. Some of the same centers led the American part of the Human Genome Project 20 years ago.
Playing catch up: The US gene database will be big … but late to the party. A similar resource in the United Kingdom, the UK Biobank, got under way a decade ago and has been wowing researchers with data on 500,000 mostly middle-aged Britons.
Deep Dive
Biotechnology and health
How scientists traced a mysterious covid case back to six toilets
When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.
An AI-driven “factory of drugs” claims to have hit a big milestone
Insilico is part of a wave of companies betting on AI as the "next amazing revolution" in biology
The quest to legitimize longevity medicine
Longevity clinics offer a mix of services that largely cater to the wealthy. Now there’s a push to establish their work as a credible medical field.
There is a new most expensive drug in the world. Price tag: $4.25 million
But will the latest gene therapy suffer the curse of the costliest drug?
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.